This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Theodore Van Putten, MD; Evelyn Crumpton, PhD; Coralee Yale, MS

Arch Gen Psychiatry. 1976;33(12):1443-1446.

Abstract
• The extremes of drug compliance were studied in two groups of schizophrenics: 29 habitual drug-refusers who invariably discontinued medication only to be readmitted several months later, and 30 drug-complier patients who habitually came in for their refills or injections of antipsychotic medication. The drug-refusers experienced the resurgence of an ego-syntonic grandiose psychosis after they discontinued medication. The habitual compliers, in contrast, developed decompensations characterized by such dysphoric affects as depression, anxiety, virtual absence of grandiosity, and some awareness of illness. The refusal of these chronic schizophrenics to take their medication could not be attributed to social isolation, paranoid diagnosis, or secondary gain. A discriminant function analysis showed grandiosity to be the most powerful discriminating variable between the two groups. We interpret these findings to mean that some schizophrenics may prefer an ego-syntonic grandiose psychosis to a relative drug-induced normality.

Author Affiliations
From the Veterans Administration Hospital (Brentwood) and the Department of Psychiatry (Drs Van Putten and Crumpton) and Biomathematics (Ms Yale), University of California, Los Angeles.

Footnotes
Accepted for publication July 27, 1976.

Reprint requests to Veterans Administration Hospital (Brentwood), Wilshire & Sawtelle Blvd, Los Angeles, CA 90073 (Dr Van Putten).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Insight and Psychosis: Comparing the Perspectives of Patient, Entourage and Clinician
Tranulis et al.
Int J Soc Psychiatry 2008;54:225-241.
ABSTRACT  

Why don't patients take their medicine? Reasons and solutions in psychiatry
Mitchell and Selmes
Adv. Psychiatr. Treat. 2007;13:336-346.
ABSTRACT | FULL TEXT  

Best Practices: A Systematic Approach to the Management of Patients Who Refuse Medications in an Assertive Community Treatment Team Setting
Tam and Law
Psychiatr. Serv. 2007;58:457-459.
ABSTRACT | FULL TEXT  

Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride
Linden et al.
J Psychopharmacol 2006;20:815-823.
ABSTRACT  

Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Velligan et al.
Schizophr Bull 2006;32:724-742.
ABSTRACT | FULL TEXT  

Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia
Olfson et al.
Psychiatr. Serv. 2000;51:216-222.
ABSTRACT | FULL TEXT  

Non-Compliance With Treatment in Patients Suffering From Schizophrenia: a Study To Evaluate Possible Contributing Factors
Agarwal et al.
Int J Soc Psychiatry 1998;44:92-106.
ABSTRACT  

Compliance therapy in psychotic patients: randomised controlled trial
Kemp et al.
BMJ 1996;312:345-349.
ABSTRACT | FULL TEXT  

Predicting Adherence to Medications by Hispanics with Schizophrenia
Hosch et al.
Hispanic Journal of Behavioral Sciences 1995;17:320-333.
ABSTRACT  

Awareness of Illness in Schizophrenia and Schizoaffective and Mood Disorders
Amador et al.
Arch Gen Psychiatry 1994;51:826-836.
ABSTRACT  

Damage Remedies and Institutional Reform: The Right to Refuse Treatment
Furrow
J Law Med Ethics 1982;10:152-157.
 

Relapse in Schizophrenia
Goldhamer
Arch Gen Psychiatry 1981;38:842-843.
ABSTRACT  

The New Asylums in the Community
Lamb
Arch Gen Psychiatry 1979;36:129-134.
ABSTRACT